Skip to main content

Table 1 Specific viral reactivation and mortality

From: Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

 

CMV

EBV

HSV-1

HSV-2

Reactivation (%)

61%

65%

48%

2.5%

Mortality among reactivated patients (%)

67%

64%

66%

100%

Media delay between ICU admission and DNAemia detection (days [IR])

8 [3–13]

4 [2–7]

5 [3–8]

  1. CMV (Cytomegalovirus), EBV (Epstein–Barr Virus), HSV-1 (Herpes Simplex Virus 1), HSV-2 (Herpes Simplex Virus 2)